Screener / SEC EDGAR /CIK 0000096943 /10-K filed Feb 27, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

Teleflex Inc TFX

Compare with peers Embed
Planned sales, announced before they happen

0 trading plans running

10-Q, 10-K and Form 144
Plans running now 0 none adopted and not yet ended or expired
Plans adopted 3 reported since May 4, 2023 Form 144 notices 0 none downloaded

What TFX's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From May 9, 2023 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Thomas E. Powell
President and Chief Financial Officer
Adopted 10b5-1 plan Aug 23, 2024 10-Q Oct 31, 2024
What the company wrote
As previously disclosed in the Form 8-K filed on August 29, 2024, on August 23, 2024, Thomas E. Powell, our Executive Vice President and Chief Financial Officer, adopted a trading plan for the sale of shares of our common stock, which plan is intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) (a “10b5-1 Plan”) under the Securities Exchange Act of 1934, as amended. The 10b5-1 Plan provides for the sale in the open market of up to 53,754 shares of our common stock issuable to Mr. Powell upon the exercise of stock options. Sales under the Plan are scheduled to take place periodically beginning in December 2024. Any shares that are sold under the Plan will be sold on the open market, subject to minimum price thresholds specified in the Plan. If any shares remain unsold following the scheduled sale dates because the minimum price threshold was not available, the shares may be sold thereafter through November 2025, subject to a specified minimum price threshold.
Liam J. Kelly
Chairman, President and Chief Executive Officer
Adopted 10b5-1 plan May 7, 2024 10-Q Aug 2, 2024
What the company wrote
As previously disclosed in the Form 8-K filed on May 9, 2024, on May 7, 2024, Liam J. Kelly, our Chairman, President and Chief Executive Officer, adopted a trading plan for the sale of shares of our common stock, which plan is intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) (a “10b5-1 Plan”) under the Securities Exchange Act of 1934, as amended. The 10b5-1 Plan provides for the sale in the open market of up to 36,464 shares of our common stock issuable to Mr. Kelly upon the exercise of stock options, which are scheduled to expire in 2025. Sales under the 10b5-1 Plan are scheduled to take place in two tranches, with the first occurring in November 2024 and the second occurring in December 2024. Any shares that are sold under the Plan will be sold on the open market, subject to minimum price thresholds specified in the Plan. If any shares remain unsold following the scheduled sale dates because the minimum price threshold was not available, the shares may be sold thereafter through January 2025, subject to a specified minimum price threshold.
Cameron Hicks
Corporate Vice President and Chief Human Resources Officer
Adopted 10b5-1 plan May 9, 2023 10-Q Aug 3, 2023
What the company wrote
On May 9, 2023, Cameron Hicks, our Corporate Vice President and Chief Human Resources Officer, adopted a trading plan for the sale of shares of our common stock, which plan is intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) (a “10b5-1 Plan”) under the Securities Exchange Act of 1934, as amended. The 10b5-1 Plan provides for the sale in the open market of up to 3,001 shares of our common stock issuable to Mr. Hicks upon the exercise of stock options with expiration dates within the next two years. The 10b5-1 Plan calls for the sales to be completed during a period beginning on August 8, 2023 and ending on May 9, 2024.

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

No Form 144 notices downloaded.

From the Form 144 XML filed with the SEC. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TFX/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.